Your Global CDMO

As a global CDMO headquartered in Munich, Germany, we are committed to fulfilling the pharmaceutical needs of clients throughout Europe, Japan and North America. Our approach is rooted in a customer-centric philosophy that guarantees exceptional quality and service in every aspect.

Our Offering

We are a reliable partner providing comprehensive Development and Manufacturing services for your drug product. End-to-end service offering for your small molecule finished dosage forms (FDFs), including sterile and non-sterile liquids, solids, and semi-solids products.

We provide customised services designed to meet the diverse needs of the industry. From out-licensing and supply to one-off analysis, custom developments, and advanced formulation services.

Read more ->

Our manufacturing network includes three state-of-the-art facilities in Europe and one in Japan, each staffed with a dedicated team committed to delivering unparalleled quality in every offering and solution we provide.

Read more ->

As part of our services, we offer a diverse portfolio of products available for licensing out to our clients worldwide.

Read more ->

We offer fully integrated services covering the entire process: from initial planning and supply chain management to regulatory affairs, for your drug product.

Read more ->

Our Team

Welcome to our team, where the vision of the Board, the leadership of the Management team and the dedication of the operational staff come together. We are not just colleagues, we are the Adragos family dedicated to making a difference.

  • Management
  • Board of Directors
  • Our Team

Our Management

Our leadership team has a long-standing and impressive track record in the pharmaceutical industry and CDMOs, demonstrating expertise and experience.

Our Team

Meet the dynamic individuals behind our success. Each member brings unique skills and perspectives that shape our company culture and drive our vision.

News

Find out more about our recent acquisitions, new developments and events we are attending.

Subscribe to our newsletter!

Get notified on our latest news.